Avinger, Inc. (AVGR)

Compare

0.4740

-0.1240

(-20.74%)

At close: February 14 at 4:00:00 PM EST

Q3 2024 Avinger Inc Earnings Call

Q3 2024 Avinger Inc Earnings Call

Thomson Reuters StreetEvents 4 months ago

AVGR
-20.74%
Avinger Inc (AVGR) Q3 2024 Earnings Call Highlights: Strategic Realignment and Product Launches ...

Avinger Inc (AVGR) reports improved gross margins and operational efficiency amid strategic realignment and successful product launches.

GuruFocus.com 4 months ago

AVGR
-20.74%
Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of 10.34% and 3.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 months ago

AVGR
-20.74%
STXS
Avinger: Q3 Earnings Snapshot

REDWOOD CITY, Calif. AP) — Avinger Inc. AVGR) on Thursday reported a loss of $4.1 million in its third quarter.

Associated Press Finance 4 months ago

AVGR
-20.74%
Avinger Reports Third Quarter 2024 Results

Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only ...

ACCESS Newswire 4 months ago

AVGR
-20.74%
Avinger to Announce Third Quarter 2024 Results on November 7, 2024

REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, ...

ACCESS Newswire 4 months ago

AVGR
-20.74%
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

REDWOOD CITY, CA / ACCESSWIRE / October 24, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease ...

ACCESS Newswire 5 months ago

AVGR
-20.74%
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, ...

ACCESS Newswire 6 months ago

AVGR
-20.74%
Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment

Avinger (AVGR) fully launches Pantheris LV, the first image-guided atherectomy system for large vessels, thus enhancing peripheral artery disease treatment with advanced technology.

Zacks 7 months ago

AVGR
-20.74%
UHS

DGX
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

REDWOOD CITY, CA / ACCESSWIRE / August 20, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, ...

ACCESS Newswire 7 months ago

AVGR
-20.74%
Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of -555.81% and 27.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 7 months ago

AVGR
-20.74%
Avinger: Q2 Earnings Snapshot

REDWOOD CITY, Calif. AP) — Avinger Inc. AVGR) on Thursday reported a loss of $4.4 million in its second quarter.

Associated Press Finance 7 months ago

AVGR
-20.74%
Avinger Reports Second Quarter 2024 Results

Implements Lower Operating Cost Profile, Readying OCT-Guided Coronary Device for IDE Submission REDWOOD CITY, CA / ACCESSWIRE / August 8, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first ...

ACCESS Newswire 7 months ago

AVGR
-20.74%
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

REDWOOD CITY, CA / ACCESSWIRE / August 5, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, ...

ACCESS Newswire 7 months ago

AVGR
-20.74%
Avinger to Announce Second Quarter 2024 Results on August 8, 2024

REDWOOD CITY, CA / ACCESSWIRE / July 29, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, ...

ACCESS Newswire 7 months ago

AVGR
-20.74%
Avinger Announces Closing of up to $24 Million Public Offering

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage ...

ACCESS Newswire 9 months ago

AVGR
-20.74%
Avinger Announces Pricing of up to $24 Million Public Offering

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage ...

ACCESS Newswire 9 months ago

AVGR
-20.74%
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular ...

ACCESS Newswire 9 months ago

AVGR
-20.74%
Are Medical Stocks Lagging Avinger (AVGR) This Year?

Here is how Avinger (AVGR) and Ayr Wellness Inc. (AYRWF) have performed compared to their sector so far this year.

Zacks 10 months ago

AVGR
-20.74%
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular ...

ACCESS Newswire 10 months ago

AVGR
-20.74%

Performance Overview

Return	AVGR	S&P 500 (^GSPC)
YTD	-42.05%	-4.23%
1-Year	-84.12%	+7.42%
3-Year	-99.10%	+23.92%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Avinger, Inc. (AVGR)

Q3 2024 Avinger Inc Earnings Call

Avinger Inc (AVGR) Q3 2024 Earnings Call Highlights: Strategic Realignment and Product Launches ...

Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates

Avinger: Q3 Earnings Snapshot

Avinger Reports Third Quarter 2024 Results

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates

Avinger: Q2 Earnings Snapshot

Avinger Reports Second Quarter 2024 Results

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

Avinger Announces Closing of up to $24 Million Public Offering

Avinger Announces Pricing of up to $24 Million Public Offering

Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

Are Medical Stocks Lagging Avinger (AVGR) This Year?

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

Performance Overview